38 - Chronic stroke prevention Flashcards

1
Q
  • *SECONDARY Stroke Prevention**
  • *AntiPlatelet Agents**
A

COX-I
Aspirin 81 > 325 qd

ADP Inhibitors

  • *Ticlopidine 250mg BID w/food**
  • *Clopidogrel 75mg qd**

PDE inhibitor + adenosine amplifier
Aggrenox
ASA 25mg / ERD 200mg BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Secondary Stroke Prevention
CLOPIDOGREL

A

PRODRUG
Thienopyridine

Requires Loading dose:

  • *300mg - 2 hours**
  • *7mg - 2 days**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Secondary Stroke Prevention
AGGRENOX

ERD 200mg + ASA 25mg
BID

A

do NOT chew/crush/open capsule

SIDE EFFECTS:

  • *HEADACHE 40%**
  • *GI Pain / Diarrhea**
  • *Better than Each agent ALONE**
  • DOES NOT SAVE LIVES*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When would we use the combination of:

ASA + Clopidogrel?

A

MINOR STROKE** or **TIA
CHANCE 2013: NIHSS score < 3 or High Risk TIA ABCD2 Score > 4

Start BOTH within 24 hours of TIA/Stroke
VVV
continue for ONLY 21 DAYS
↓Stroke ↓MI/CV/Stroke Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When would ANTIPLATELETS be preferred
> AntiCoagulants?

A

NON-CARDIOEMBOLIC STOKES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  • *Primary Stroke Prevention**
  • *RISK FACTORS**
A

Control:
HTN / Diabetes / Hyperlipidemia

TREAT:
AFIB

Diet / Exercise

SMOKING CESSATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Secondary Stroke Prevention
RISK FACTORS

A

ALL PRIMARY
plus

CEA for carotid stenosis

AC for
Thromboembolic or hypercoagulable disease

Antiplatelet therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • *NON-MODIFIABLE**
  • *STROKE RISK FACTORS**
A

AGE > 55

FAMILY HISTORY

RACE:
AA > hispanic/asian > caucasian

Gender M > F

Prior:
Stroke / TIA / MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • *MODIFIABLE**
  • *Stroke Risk Factors**
A

High BP / DM / AFIB

SMOKING

Poor Diet / Physical Inactivity / HYPERLIPIDemia

Heart Disease / Sickle Cell

Carotid/Peripheral Artery Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Modifiable Risk Factor
HYPERTENSION

A

Lowering BP can:
Stroke Risk by 30-40%

Treatment Recommendations:
< 130/80
uncertain benefit in pts W/O HTN
May initiate treatment >24-48 hours after acute stroke

Diuretics + ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Modifiable Risk Factor
DIABETES

A

Risk of Recurrent stroke by 60%
present in 25-45% of ALL stroke patients

All Stroke pts. screened for DM:
Glucose >126 / HgbA1c _>_6.5%

***_NO single agent/class preferred_***
just want to be **CONTROLLED**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Modifiable Risk Factor
HYPERLIPIDEMIA

A

no evidence linking the
CHOLESTEROL LEVELS or LIPID LEVELS
to STROKE
BUT:
SPARCL Trial showed in:
recent stroke/TIA + LDL 100-190 + NO HISTORY OF CAD
Stroke Recurrence w/ ATORVASTATIN
↓Stroke / TIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ROLE of STATINS
In
Treatment / Prevention of Stroke

A

SPARCL TRIAL
Recent Stroke/TIA // LDL 100-190 // no h/o CAD
AHA/ASA recommends:
Intensive Statins for patients with:
Ischemic Stroke / TIA** of **Atherosclerotic Origin
AND
LDL > 100 but still recommended for LDL < 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Modifiable Risk Factor
SMOKING

A

INCLUDES SECOND HAND SMOKE

  • *2x Stroke Risk**
  • risk decreases RIGHT AFTER quitting*
  • *dissapears after 5 YEARS**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AHA/ASA Guidelines for:
Stroke Prevention in NON-Valvular AFib

A
  • *AC** may start within 14 days AFTER stroke
  • unless HIGH RISK for hemorrhage*

For patients UNABLE to take AC therapy
ASPIRIN ALONE > ASA + clopidogrel

Anticoagulant + Antiplatelet
ONLY recommended with CLINICALLY APPARENT CAD:
ACS or Cardiac stent placement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly